Obesity as a Confounding Factor in the Diagnosis of Wilson’s Disease: Case Report of Two Siblings with the Same Genotype but Different Clinical Courses

Author:

Bracciamà Emanuele1ORCID,Sapuppo Annamaria2ORCID,Rapisarda Laura34ORCID,Siciliano Enrico1ORCID,Caciotti Anna5ORCID,Morrone Amelia56ORCID,Ruggieri Martino2,Cantarella Giuseppina3ORCID,Bernardini Renato34,Bertino Gaetano1ORCID

Affiliation:

1. Hepatology Unit, Department of Clinical and Experimental Medicine, Policlinico “G. Rodolico—San Marco” Hospital, University of Catania, 95123 Catania, Italy

2. Pediatric Clinic, Department of Clinical and Experimental Medicine, Policlinico “G. Rodolico—San Marco” Hospital, University of Catania, 95123 Catania, Italy

3. Department Biomedical and Biotechnological Sciences (BIOMETC), Section of Pharmacology, University of Catania, 95123 Catania, Italy

4. Clinical Toxicology Unit, Policlinico “G. Rodolico-San Marco” Hospital, 95123 Catania, Italy

5. Laboratory of Molecular Biology of Neurometabolic Diseases, Neuroscience Department, Meyer Children’s Hospital IRCCS, 50139 Florence, Italy

6. Department of NEUROFARBA, University of Florence, 50121 Florence, Italy

Abstract

Wilson’s disease (WD) is a biallelic disease-causing variant in the ATP7B gene on chromosome 13q14.3 that results in copper accumulation in many organs, particularly the liver and brain. The phenotypic spectrum is wide and symptoms at onset can be heterogeneous. We describe two Sicilian siblings, a young man and his elder sister, both compound heterozygous for the variants c.1286-2A>G and c.2668G>A (p.Val890Met) in the ATB7B gene. The male patient presented with liver cirrhosis, which quickly progressed to end-stage liver disease (Child–Pugh score = C10), while his sister had moderate steatotic liver disease (SLD). Our findings highlight that SLD may not always be related to obesity in overweight patients, especially when there are other potential risk factors such as a family history of chronic liver disease, or the persistence of high transaminase despite the adoption of adequate dietary and pharmacological intervention. Screening for conditions such as WD could identify patients at risk of developing SLD and avoid delays in diagnosis. Phenotypic variability in WD is considerable; therefore, further studies are needed to identify which WD patients have a greater risk of developing SLD and determine factors that can predict the severity of the disease.

Funder

Italian Ministry of Health

Publisher

MDPI AG

Reference18 articles.

1. A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases;Schilsky;Hepatology,2023

2. Wilson disease;Litwin;Nat. Rev. Dis. Primers,2018

3. Neurological-Type Wilson Disease: Epidemiology, Clinical Manifestations, Diagnosis, and Management;Kipker;Cureus,2023

4. Wilson’s disease: A review of what we have learned;Sturniolo;World J. Hepatol.,2015

5. Epidemiology and introduction to the clinical presentation of Wilson disease;Lo;Handb. Clin. Neurol.,2017

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Wilson Disease: Diagnostic Challenges and Differential Diagnoses;Clinical & Translational Metabolism;2024-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3